Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.
Accelerate early toxicity screening with a cost-effective, high-throughput vertebrate model that integrates behavioral, histopathological, and biochemical endpoints to identify neurotoxic and systemic risks before advancing to mammalian studies.
Validate molecular targets, elucidate signaling cascades, and quantify gene expression changes in a high-throughput in vivo vertebrate model. Our zebrafish platform enables rapid, cost-effective assessment of inflammation, muscle health, and disease pathways with direct translational relevance.
Our Zebrafish Disease Model Construction Service provides end-to-end support for creating genetically defined models that recapitulate human disease pathology.
The zebrafish (Danio rerio) model bridges the gap between in vitro assays and mammalian studies, offering a whole-organism context that reveals systemic drug effects – from target engagement to behavioral and metabolic outcomes.
Zebrafish (Danio rerio) have emerged as a powerful vertebrate model for preclinical efficacy testing, offering a unique combination of optical transparency, high fecundity, and genetic homology to humans—approximately 70% of human disease genes have a zebrafish orthologue.
The larval zebrafish (Danio rerio) has become a powerful vertebrate model for identifying compounds that modulate nervous system activity.
Cosmetic ingredient developers and pharmaceutical teams face a common challenge: cell-based assays lack whole-organism context, yet mammalian models are slow and costly for early-stage screening.
Drug-induced liver injury (DILI) remains a leading cause of attrition during both early and late-stage drug development, as well as post-marketing withdrawals.
Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the selective loss of dopaminergic neurons in the brain.
Our service provides quantitative readouts of melanocyte differentiation and melanin production, critical for evaluating compounds targeting pigmentation pathways.
In vivo calcium imaging enables direct visualization of neuronal activity by recording fluorescence changes from genetically encoded calcium indicators (GECIs) such as GCaMP6s.
Identifying developmental toxicity risks early in drug and chemical development is critical to avoid costly late-stage failures.
Zebrafish (Danio rerio) have become a cornerstone of preclinical drug discovery, offering a unique balance between the genetic tractability of invertebrate models and the physiological complexity of rodents.
Each year, thousands of compounds must be screened for developmental toxicity during pharmaceutical and chemical development.
Retinal toxicity remains a leading cause of late-stage attrition in ophthalmic drug development. Standard rodent models, though predictive, are slow and resource-intensive, often delaying candidate selection.
Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.